Cambridge Investment Research Advisors, Inc. Biomerica Inc Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Biomerica Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 10,125 shares of BMRA stock, worth $9,618. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,125Holding current value
$9,618% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BMRA
# of Institutions
26Shares Held
1.59MCall Options Held
23.3KPut Options Held
0-
Granahan Investment Management, LLC Waltham, MA659KShares$625,8280.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA169KShares$160,5590.0% of portfolio
-
Potomac Capital Management, Inc.168KShares$159,3150.37% of portfolio
-
Black Rock Inc. New York, NY149KShares$141,6260.0% of portfolio
-
Geode Capital Management, LLC Boston, MA119KShares$112,5770.0% of portfolio
About BIOMERICA INC
- Ticker BMRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 13,427,700
- Market Cap $12.8M
- Description
- Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...